Intrinsic Value of S&P & Nasdaq Contact Us

Solventum Corporation SOLV NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
73/100
6/7 Pass
SharesGrow Intrinsic Value
$6.98
-89.9%
Analyst Price Target
$100.50
+45.6%

Solventum Corporation (SOLV) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 7 recommend buying, 3 recommend holding, and 1 recommend selling.

The analyst consensus price target for SOLV is $100.50, representing a +45.6% upside from the current price of $69.02. Price targets range from a low of $97.00 to a high of $105.00.

Analyst Consensus — SOLV

Buy
Strong Buy
0
Buy
7
Hold
3
Sell
1
Strong Sell
0
11 analysts
Price Targets
Consensus$100.50
High$105.00
Low$97.00
Median$100.00
Last Month Avg-
Last Quarter Avg$98.50
Last Year Avg$97.00
All-Time Count15
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message